Dawei Shi
Nanbaixiang Street
Wenzhou, 325000, China
Wenzhou, 325000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Risk of immune system and skin and subcutaneous tissue related adverse events associated with oxaliplatin combined with immune checkpoint inhibitors: a pharmacovigilance study.
Journal: Frontiers in pharmacology
Published: October 08, 2023
Linezolid and the risk of QT interval prolongation: A pharmacovigilance study of the Food and Drug Administration Adverse Event Reporting System.
Journal: British journal of clinical pharmacology
Published: June 07, 2022
Anaplastic lymphoma kinase tyrosine kinase inhibitor-induced hepatic failure in lung cancer patients: A study of signal mining and analysis of the FDA adverse event reporting system database.
Journal: Journal of clinical pharmacy and therapeutics
Published: February 01, 2021
Hepatotoxicity-Related Adverse Effects of Proton Pump Inhibitors: A Cross-Sectional Study of Signal Mining and Analysis of the FDA Adverse Event Report System Database.
Journal: Frontiers in medicine
Published: December 31, 2020
An investigation into possible interactions among four vascular epidermal growth factor receptor-tyrosine kinase inhibitors with gefitinib.
Journal: Cancer chemotherapy and pharmacology
Published: July 05, 2020
Linezolid and the risk of lactic acidosis: Data mining and analysis of the FDA Adverse Event Reporting System.
Journal: Journal of clinical pharmacy and therapeutics
Published: June 17, 2020
Hypoglycemia Induced by Hydroxychloroquine Sulfate in a Patient Treated for Connective Tissue Disease Without Diabetes Mellitus.
Journal: Clinical therapeutics
Published: December 17, 2019
Characterization of binding interaction between magnesium isoglycyrrhizinate and human serum albumin.
Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
Published: December 12, 2019
The inhibitory effects of shikonin and β,β-dimethylacrylshikonin on tramadol metabolism in vitro and in vivo.
Journal: The Journal of pharmacy and pharmacology
Published: October 10, 2019
Proton Pump Inhibitor Therapy and Hepatic Encephalopathy Risk in Cirrhotic Patients: A Systematic Review with Meta-analysis.
Journal: Clinical drug investigation
Published: June 12, 2019
Clinical characteristics and risk factors of severe hyponatremia in cirrhotic patients treated with terlipressin.
Journal: Journal of clinical pharmacy and therapeutics
Published: May 21, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026